Alveron Pharma
Manufacturing · Netherlands · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Gasstraat Kantoor 2.16 20, Oss, North Br...Website
www.alveron.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Alveron Pharma
Alveron is a clinical-stage company developing OKL-1111 as a first-line intravenously-administered therapy to treat intracranial haemorrhage (ICH) associated with anticoagulant and/or platelet inhibitor use. OKL-1111’s novel mechanism of action and product profile could enable a significant reduction in the time required to halt bleeding as compared to other reversal approaches, to limit hematoma expansion and improve clinical outcomes including mortality and morbidity.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Alveron Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Alveron Pharma launches new products
Alveron Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Alveron Pharma has recently received funding, and reach out quickly before it becomes old news!
Click to see if Alveron Pharma had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Alveron Pharma
Check out if Alveron Pharma is spiking on competitors!
Earning: See what the market has to say on Alveron Pharma recently announced quarterly report
Funding: Get notified immidiatlly once Alveron Pharma has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Alveron Pharma
Compare insights from companies similar to Alveron Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Alveron Pharma
<$5M
1-10
Private
$9.5M
2019
N/A
Company Profile Activity
Activity Insights
Alveron Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Alveron Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Alveron Pharma.
Alveron Pharma financials insights
Gather financial insights about Alveron Pharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Angel/Seed
$9.5M
Alveron Pharma Tech Stack
A closer look at the technologies used by Alveron Pharma
Alveron Pharma News & Media
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Alveron Pharma
Sign Up For FreeTo access detailed company insights
Alveron is a clinical-stage company developing OKL-1111 as a first-line intravenously-administered therapy to treat intracranial haemorrhage (ICH) associated with anticoagulant and/or platelet inhibitor use. OKL-1111’s novel mechanism of action and product profile could enable a significant reduction in the time required to halt bleeding as compare... Read More
